CSF Liquid Biopsy May Improve Diagnosis of Leptomeningeal Disease
A study reports that CSF liquid biopsy measuring variant allele frequency may improve leptomeningeal disease diagnosis, especially when MRI and cytology are inconclusive.
Read MorePosted by CLP Edit Staff | Apr 24, 2026 | Molecular Diagnostics |
A study reports that CSF liquid biopsy measuring variant allele frequency may improve leptomeningeal disease diagnosis, especially when MRI and cytology are inconclusive.
Read MorePosted by CLP Edit Staff | Apr 22, 2026 | Cancer, Molecular Diagnostics |
Ultima Genomics presented data at AACR 2026 showing its ppmSeq technology detected circulating tumor DNA at low single-digit parts-per-million in a TRACERx pilot of 50 plasma samples.
Read MorePosted by CLP Edit Staff | Apr 22, 2026 | Cancer, Company News, Molecular Diagnostics |
TCM Biotech has received FDA Breakthrough Device Designation for CatCHimera, a liquid biopsy platform for monitoring minimal residual disease in hepatocellular carcinoma using HBV–host genome integration biomarkers.
Read MorePosted by CLP Edit Staff | Apr 20, 2026 | Anatomic Pathology, Company News, Digital Pathology |
The seed funding will support the commercialization of a platform designed to generate biomarker insights from pathology images without laboratory staining.
Read MorePosted by CLP Edit Staff | Apr 20, 2026 | Analytical Software Systems, Lung Cancer |
AI integrated into molecular profiling workflows identified misclassified lung cancer cases, highlighting its potential role in improving diagnostic accuracy in clinical labs.
Read More